Wave 80 Biosciences

Jump to Current Jobs at Wave 80 Biosciences

Wave 80 Biosciences develops next-generation molecular diagnostics instruments and consumables for hepatitis C, hepatitis B, HIV/AIDS, and other human health conditions. Distinguished by a novel one patient-one test usage model, best-in-class performance, and a superior value proposition, Wave 80's pipeline products address unmet needs of diverse patient populations worldwide in the high-clinical-value molecular diagnostics segment of the clinical laboratory testing systems market.

Web Site:	www.wave80.com
Headquarters:	2325 Third St. Suite 215 San Francisco, CA 94107 United States
Employees:	11-40
Year Founded:	2003
Industry:	Medical Devices and Equipment

About Wave 80 Biosciences:

Wave 80 Biosciences, Inc. develops next-generation molecular diagnostics products for infectious disease, cancer, autoimmune disease, and other human health conditions. The company began operations in 2003, with a small team of engineers, biologists, and chemists working out of warehouse space in San Francisco's Dogpatch neighborhood to develop new high-performance, cost-effective technologies for processing complex fluid samples. The company quickly made breakthroughs in life sciences applications ranging from immunotherapeutics to biomolecular analysis, including demonstrating in 2005 the first fully automated field-use system for quantitative multiplexed immunoassays. In 2007, Wave 80 initiated a development program combining novel nucleic acid assay methods with fluid transport technology adapted from integrated circuit thermal management to address emerging needs for viral load monitoring to accompany expanding access to antiretroviral therapy among the estimated 30 million people living with HIV in low- and middle-income countries. The first versions of the EOSCAPE-HIV system are scheduled to enter beta testing in clinics in Kenya and South Africa in 2011.

Wave 80 Biosciences Jobs